In Vitro Potency of CXA-101, a Novel Cephalosporin, against Pseudomonas aeruginosa Displaying Various Resistance Phenotypes, Including Multidrug Resistance

We describe the activity of a novel cephalosporin, CXA-101 (FR26 4205), against a panel of highly resistant Pseudomonas aeruginosa isolates collected from U.S. hospitals. CXA-101 demonstrated increased potency against this population of resistant isolates, with activity that is 4- to 10-fold higher...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Bulik, Catharine C., Christensen, Henry, Nicolau, David P.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2010
נושאים:
Susceptibility
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798502/
https://ncbi.nlm.nih.gov/pubmed/19917762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00912-09
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים